Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Adenosine + thrombolytics further reduces infarct size in acute MI; phase III trials in preparation

Nov. 23, 1998

New MMP inhibitor from Roche Bioscience limits arterial enlargement in rat model of AVF

Nov. 23, 1998

Celgene describes SelCID compounds for treatment of CHF

Nov. 20, 1998

Nortran enters collaborative agreement with Astra

Nov. 20, 1998

Ozagrel hydrochloride effectively prevents development of preeclampsia in pregnant women

Nov. 19, 1998

Safe and effective treatment of acute CHF with nesiritide

Nov. 19, 1998

Endothelin antagonists a focus of R&D at Merck KGaA

Nov. 19, 1998

New compound described for the treatment of pregnancy-induced hypertension

Nov. 19, 1998

5-HT antagonists in development at Synthelabo for cardiovascular and other disorders

Nov. 18, 1998

Synthesis and use of novel ET-antagonist series disclosed by Merck KGaA

Nov. 18, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...